G1 cell cycle arrest due to the inhibition of erbB family receptor tyrosine kinases does not require the retinoblastoma protein

Experimental Cell Research

Volumn 303, Issue 1, 2005, Pages 56-67

  Gonzales, Andrea J ^a   Fry, David W ^a  

^a PFIZER INC   (United States)

Author keywords

Cell cycle arrest; erbB family; Retinoblastoma protein

Indexed keywords

4 (3 BROMOANILINO) 6 (METHYLAMINO)PYRIDO[3,4 D]PYRIMIDINE; CYCLIN E; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; NEU DIFFERENTIATION FACTOR; PROTEIN P107; PROTEIN P130; PROTEIN P27; PROTEIN TYROSINE KINASE; RETINOBLASTOMA PROTEIN;

ARTICLE; AUTOPHOSPHORYLATION; BREAST EPITHELIUM; CELL CYCLE G1 PHASE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 9644276724     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.08.040     Document Type: Article

References (63)

1. N. Prenzel, O.M. Fischer, S. Streit, S. Hart, and A. Ullrich The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification Endocr. Relat. Cancer 8 2001 11 31
2. K.D. Brown The epidermal growth factor/transforming growth factor-alpha family and their receptors Eur. J. Gastroenterol. Hepatol. 7 1995 914 922
3. Y. Yarden, and M.X. Sliwkowski Untangling the ErbB signalling network Nat. Rev., Mol. Cell Biol. 2 2001 127 137
4. R.N. Jorissen, F. Walker, N. Pouliot, T.P. Garrett, C.W. Ward, and A.W. Burgess Epidermal growth factor receptor: mechanisms of activation and signalling Exp. Cell Res. 284 2003 31 53
5. C.J. Marshall Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation Cell 80 1995 179 185
6. C.H. Heldin Protein tyrosine kinase receptors Cancer Surv. 27 1996 7 24
7. H. Matsushime, M.F. Roussel, and C.J. Sherr Novel mammalian cyclins (CYL genes) expressed during G1 Cold Spring Harbor Symp. Quant. Biol. 56 1991 69 74
8. H. Matsushime, M.F. Roussel, R.A. Ashmun, and C.J. Sherr Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle Cell 65 1991 701 713
9. C.J. Sherr Growth factor-regulated G1 cyclins Stem Cells 1 Suppl. 1 1994 47 55
10. C.J. Sherr, J. Kato, D.E. Quelle, M. Matsuoka, and M.F. Roussel D-type cyclins and their cyclin-dependent kinases: G1 phase integrators of the mitogenic response Cold Spring Harbor Symp. Quant. Biol. 59 1994 11 19
11. C.J. Sherr G1 phase progression: cycling on cue Cell 79 1994 551 555
12. C.J. Sherr Mammalian G1 cyclins Cell 73 1993 1059 1065
13. J. Pines Cyclins and cyclin-dependent kinases: take your partners Trends Biochem. Sci. 18 1993 195 197
14. R.A. Weinberg The retinoblastoma protein and cell cycle control Cell 81 1995 323 330
15. N. Dyson The regulation of E2F by pRB-family proteins Genes Dev. 12 1998 2245 2262
16. KIP1 and induces G1 arrest in prostatic cancer cell line DU145 Cancer Res. 56 1996 3666 3669
17. KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody Oncogene 12 1996 1397 1403
18. Kip1) and p21(Cip1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors Clin. Cancer Res. 3 1997 1943 1948
19. J.D. Moyer, E.G. Barbacci, K.K. Iwata, L. Arnold, B. Boman, A. Cunningham, C. DiOrio, J. Doty, M.J. Morin, M.P. Moyer, M. Neveu, V.A. Pollack, L.R. Pustilnik, M.M. Reynolds, D. Sloan, A. Theleman, and P. Miller Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase Cancer Res. 57 1997 4838 4848
20. KIP1) independent of MAPK activity J. Biol. Chem. 275 2000 6987 6995
21. X.F. Zhu, Z.C. Liu, B.F. Xie, Z.M. Li, G.K. Feng, D. Yang, and Y.X. Zeng EGFR tyrosine kinase inhibitor AG1478 inhibits cell proliferation and arrests cell cycle in nasopharyngeal carcinoma cells Cancer Lett. 169 2001 27 32
22. KIP1) and p15(INK4B) and induces G1 arrest in oral squamous carcinoma cell lines Oncology 63 2002 92 98
23. WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells J. Cell Physiol. 195 2003 139 150
24. KIP1 and induces G1 arrest in oral squamous cell carcinoma cell lines Oral Oncol. 40 2004 43 51
25. F.M. Yakes, W. Chinratanalab, C.A. Ritter, W. King, S. Seelig, and C.L. Arteaga Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action Cancer Res. 62 2002 4132 4141
26. A.E. Lenferink, D. Busse, W.M. Flanagan, F.M. Yakes, and C.L. Arteaga ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways Cancer Res. 61 2001 6583 6591
27. G.W. Rewcastle, D.K. Murray, W.L. Elliott, D.W. Fry, C.T. Howard, J.M. Nelson, B.J. Roberts, P.W. Vincent, H.D. Showalter, R.T. Winters, and W.A. Denny Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)- pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors J. Med. Chem. 41 1998 742 751
28. D.W. Fry, J.M. Nelson, V. Slintak, P.R. Keller, G.W. Rewcastle, W.A. Denny, H. Zhou, and A.J. Bridges Biochemical and antiproliferative properties of 4-[ar(alk)ylamino]pyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitor Biochem. Pharmacol. 54 1997 877 887
29. A.J. Gonzales, T.L. Goldsworthy, and T.R. Fox Chemical transformation of mouse liver cells results in altered cyclin D-CDK protein complexes Carcinogenesis 19 1998 1093 1102
30. J. Brugarolas, K. Moberg, S.D. Boyd, Y. Taya, T. Jacks, and J.A. Lees Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation Proc. Natl. Acad. Sci. U. S. A. 96 1999 1002 1007
31. R.J. Slebos, M.H. Lee, B.S. Plunkett, T.D. Kessis, B.O. Williams, T. Jacks, L. Hedrick, M.B. Kastan, and K.R. Cho p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein Proc. Natl. Acad. Sci. U. S. A. 91 1994 5320 5324
32. G.W. Demers, S.A. Foster, C.L. Halbert, and D.A. Galloway Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7 Proc. Natl. Acad. Sci. U. S. A. 91 1994 4382 4386
33. G. Mulligan, and T. Jacks The retinoblastoma gene family: cousins with overlapping interests Trends Genet. 14 1998 223 229
34. X. Grana, J. Garriga, and X. Mayol Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth Oncogene 17 1998 3365 3383
35. C.J. Sherr, and J.M. Roberts CDK inhibitors: positive and negative regulators of G1-phase progression Genes Dev. 13 1999 1501 1512
36. J.W. Harbour, and D.C. Dean The Rb/E2F pathway: expanding roles and emerging paradigms Genes Dev. 14 2000 2393 2409
37. J. Lukas, T. Herzinger, K. Hansen, M.C. Moroni, D. Resnitzky, K. Helin, S.I. Reed, and J. Bartek Cyclin E-induced S phase without activation of the pRB/E2F pathway Genes Dev. 11 1997 1479 1492
38. G. Leone, J. DeGregori, R. Sears, L. Jakoi, and J.R. Nevins Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F Nature 387 1997 422 426
39. G. Leone, J. DeGregori, L. Jakoi, J.G. Cook, and J.R. Nevins Collaborative role of E2F transcriptional activity and G1 cyclin-dependent kinase activity in the induction of S phase Proc. Natl. Acad. Sci. U. S. A. 96 1999 6626 6631
40. R.J. Duronio, A. Brook, N. Dyson, and P.H. O'Farrell E2F-induced S phase requires cyclin E Genes Dev. 10 1996 2505 2513
41. C. Bouchard, P. Staller, and M. Eilers Control of cell proliferation by Myc Trends Cell Biol. 8 1998 202 206
42. K. Alevizopoulos, J. Vlach, S. Hennecke, and B. Amati Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins EMBO J. 16 1997 5322 5333
43. E. Santoni-Rugiu, J. Falck, N. Mailand, J. Bartek, and J. Lukas Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRB/E2F pathway Mol. Cell. Biol. 20 2000 3497 3509
44. J. Bartek, and J. Lukas Pathways governing G1/S transition and their response to DNA damage FEBS Lett. 490 2001 117 122
45. K. Keyomarsi, and T.W. Herliczek The role of cyclin E in cell proliferation, development and cancer Prog. Cell Cycle Res. 3 1997 171 191
46. K. Keyomarsi, S.L. Tucker, T.A. Buchholz, M. Callister, Y. Ding, G.N. Hortobagyi, I. Bedrosian, C. Knickerbocker, W. Toyofuku, M. Lowe, T.W. Herliczek, and S.S. Bacus Cyclin E and survival in patients with breast cancer N. Engl. J. Med. 347 2002 1566 1575
47. J. Tsihlias, L. Kapusta, and J. Slingerland The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer Annu. Rev. Med. 50 1999 401 423
48. P.L. Porter, K.E. Malone, P.J. Heagerty, G.M. Alexander, L.A. Gatti, E.J. Firpo, J.R. Daling, and J.M. Roberts Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients Nat. Med. 3 1997 222 225
49. C. Xiangming, S. Natsugoe, S. Takao, S. Hokita, G. Tanabe, M. Baba, K. Kuroshima, and T. Aikou The cooperative role of p27 with cyclin E in the prognosis of advanced gastric carcinoma Cancer 89 2000 1214 1219
50. KIP1) in cervical carcinoma Cancer Lett. 153 2000 41 50
51. J. Bartek, J. Bartkova, and J. Lukas The retinoblastoma protein pathway in cell cycle control and cancer Exp. Cell Res. 237 1997 1 6
52. M.M. Lipinski, and T. Jacks The retinoblastoma gene family in differentiation and development Oncogene 18 1999 7873 7882
53. D. Cobrinik, M.H. Lee, G. Hannon, G. Mulligan, R.T. Bronson, N. Dyson, E. Harlow, D. Beach, R.A. Weinberg, and T. Jacks Shared role of the pRB-related p130 and p107 proteins in limb development Genes Dev. 10 1996 1633 1644
54. S.C. Lin, S.X. Skapek, and E.Y. Lee Genes in the RB pathway and their knockout in mice Semin. Cancer Biol. 7 1996 279 289
55. G.J. Mulligan, J. Wong, and T. Jacks p130 is dispensable in peripheral T lymphocytes: evidence for functional compensation by p107 and pRB Mol. Cell. Biol. 18 1998 206 220
56. X. Mayol, J. Garriga, and X. Grana Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130 Oncogene 11 1995 801 808
57. J. Garriga, A. Limon, X. Mayol, S.G. Rane, J.H. Albrecht, E.P. Reddy, V. Andres, and X. Grana Differential regulation of the retinoblastoma family of proteins during cell proliferation and differentiation Biochem. J. 333 Pt. 3 1998 645 654
58. D.G. Johnson, and R. Schneider-Broussard Role of E2F in cell cycle control and cancer Front. Biosci. 3 1998 d447 d448
59. K. Hansen, T. Farkas, J. Lukas, K. Holm, L. Ronnstrand, and J. Bartek Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block EMBO J. 20 2001 422 432
60. S. Lacy, and P. Whyte Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes Oncogene 14 1997 2395 2406
61. M.S. Woo, I. Sanchez, and B.D. Dynlacht p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity Mol. Cell. Biol. 17 1997 3566 3579
62. E. Castano, Y. Kleyner, and B.D. Dynlacht Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor Mol. Cell. Biol. 18 1998 5380 5391
63. A.E. White, E.M. Livanos, and T.D. Tlsty Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteines Genes Dev. 8 1994 666 677